Skip to main content

drospirenone and ethinyl estradiol Medicare Part D Coverage

Brand name: OCELLA
Dosage form
KIT
80%
of Medicare Part D plans
cover drospirenone and ethinyl estradiol
4,419 of 5,530 plans
2.5
Avg. formulary tier
$12.00
Median 30-day copay
$0.00–$24.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify drospirenone and ethinyl estradiol. Lower tiers = lower copays.

Tier 1 - Preferred Generic 2%
103 plans • avg $0.00/mo
Tier 2 - Generic 50%
2,213 plans • avg $1.82/mo
Tier 3 - Preferred Brand 44%
1,928 plans • avg $1.17/mo
Tier 4 - Non-Preferred Drug 4%
175 plans • avg $2.11/mo

Find the cheapest plan for drospirenone and ethinyl estradiol

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for drospirenone and ethinyl estradiol →

Get drospirenone and ethinyl estradiol Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

drospirenone and ethinyl estradiol Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about drospirenone and ethinyl estradiol

80% of Medicare Part D plans cover drospirenone and ethinyl estradiol. It is most commonly placed on Tier 3. Coverage varies by plan and geographic area.

The median 30-day copay for drospirenone and ethinyl estradiol on Medicare Part D is $12.00 at a preferred pharmacy. Costs range from $0.00 to $24.00 depending on the plan.

drospirenone and ethinyl estradiol is placed on Tier 3 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for drospirenone and ethinyl estradiol. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →